CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-07 | Semerjian Harout President and CEO | Grant or award · Stock Option (right to buy) | +4,000,000 | 4,000,000 | ||
| 2025-06-30 | Spiegel Robert J. Director | Grant or award | +5,540 | $1.41 | $8K | 182,844 |
| 2025-05-21 | Aggarwal Gaurav Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | Bir Dawn Carter Interim President and CEO | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | McDonald John F Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-21 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-05-09 | LAWLIS V BRYAN Director | Purchase | +13,300 | $1.18 | $16K | 13,300 |
| 2025-03-31 | Spiegel Robert J. Director | Grant or award | +4,913 | $1.59 | $8K | 177,304 |
| 2025-02-27 | Samuels Scott Alan EVP, Chief Legal Officer | Purchase | +15,000 | $1.61 | $24K | 26,682 |
| 2025-02-27 | SCARLETT JOHN A Chairman, President and CEO | Purchase | +12,500 | $1.77 | $22K | 12,500 |
| 2025-02-27 | Ziegler James EVP, Chief Commercial Officer | Purchase | +100,000 | $1.60 | $160K | 100,000 |
| 2025-02-18 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Stock Option (right to buy) | +839,000 | 839,000 | ||
| 2025-02-18 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Restricted Stock Units | +140,000 | 140,000 | ||
| 2025-02-18 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +2,457,000 | 2,457,000 | ||
| 2025-02-18 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Restricted Stock Units | +410,000 | 410,000 | ||
| 2025-02-18 | Samuels Scott Alan EVP, Chief Legal Officer | Grant or award · Stock Option (right to buy) | +621,000 | 621,000 | ||
| 2025-02-18 | Samuels Scott Alan EVP, Chief Legal Officer | Grant or award · Restricted Stock Units | +104,000 | 104,000 |
Page 2 of 7 · 138 trades